immunity News and Research

RSS

Rotavirus vaccine significantly cuts child hospitalizations, study says

Developing and developed countries that require children to be vaccinated against rotavirus "have significantly reduced the number of children admitted to hospitals with the disease, a report showed on Thursday," Reuters reports (Kelland, 1/20).

24 Jan 2011

Researchers map complex choreography used by immune system's T cells to recognize pathogens

Researchers have for the first time mapped the complex choreography used by the immune system's T cells to recognize pathogens while avoiding attacks on the body's own cells.

21 Jan 2011

New research says EPO hormone can modulate immune response

New research reveals that a hormone best known for stimulating the production of red blood cells can modulate the immune response. The study, published by Cell Press in the January 27th issue of the journal Immunity, finds that erythropoietin has contrasting influences on infectious and inflammatory diseases and may be useful in the design of new therapeutic strategies.

21 Jan 2011

Routine rotavirus vaccine shows a significant drop in diarrhea cases: Study

A latest study has shown that the rotavirus vaccines have helped drastically reduce hospital visits around the world. Rotavirus can lead to fatal cases of diarrhea in children and causes half a million deaths in kids under five each year around the world. Developing countries are particularly at risk.

20 Jan 2011

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

STMicroelectronics, the leading supplier of MEMS devices for consumer and portable applications, and Bluechiip Limited, an innovative early-stage company that has developed a groundbreaking tracking solution, today announced that the two companies are to cooperate in the manufacturing of unique MEMS-based tracking tags, aimed at a range of different markets, but initially in healthcare, such as biobanks.

20 Jan 2011

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens.

20 Jan 2011

Study finds link between public transport and risk of catching ARI

You are six times more likely to end up at the doctors with an acute respiratory infection if you have recently used a bus or tram — but those who use buses or trams daily might well be somewhat protected compared with more occasional users.

19 Jan 2011

Collaborative study may lead to improved influenza vaccine and vaccines for other respiratory virus infections

A collaborative project between researchers at the Trudeau Institute and their colleagues at St. Jude Children's Research Hospital in Memphis, Tenn., offers new insights that may lead to an improved strategy to protect against the influenza virus and other viruses that infect the respiratory tract.

19 Jan 2011

Convalescent plasma therapy may reduce mortality rate in patients with H1N1 infection: Study

A study published in the February 15 issue of Clinical Infectious Diseases suggests that convalescent plasma may reduce the death rate in patients severely ill with this type of influenza.

19 Jan 2011

New patented technique offers unprecedented view of DNA damage

New technology providing the first view of DNA damage throughout the entire human genome developed by Cardiff University scientists could offer a valuable new insight into the development and treatment of conditions like cancer.

19 Jan 2011

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency (DARPA) and the Army Research Office (ARO) to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens. The ultimate goal is to develop a viable countermeasure to an unknown pathogen within seven days of receiving it in a laboratory.

19 Jan 2011

Australians urged to vaccinate babies and care givers against whooping cough

The number of cases of the deadly whooping cough in the Hume region in Victoria, including Wodonga, last year increased fivefold from those diagnosed in 2008. A total 67 cases were reported in Albury last year but across the Greater Southern region there were more than 1,000 cases. The outbreak reached its peak in September. In the last three years 1,416 West Australians contracted the disease, three of whom died.

18 Jan 2011

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

A researcher at Albert Einstein College of Medicine of Yeshiva University has helped to develop the first genetic blood test for predicting the chances that in vitro fertilization will lead to a successful pregnancy.

13 Jan 2011

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.

12 Jan 2011

Michael Cuccione Foundation donates $5 million to support childhood cancer research

The Michael Cuccione Foundation is donating $5 million to support the childhood cancer research program at the Child & Family Research Institute at BC Children's Hospital, now named the Michael Cuccione Foundation Childhood Cancer Research Program. The gift, the largest ever to cancer research at BC Children's, was announced during an event at the research institute, where the program is based.

12 Jan 2011

Antibodies produced by people who recovered from H1N1 offer clues for universal flu vaccine

The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a "universal" flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports.

12 Jan 2011

Herpes zoster vaccine reduces risk of developing shingles by 55%

Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association.

12 Jan 2011

Fertile women gravitate toward males with masculine facial features

When their romantic partners are not quintessentially masculine, women in their fertile phase are more likely to fantasize about masculine-looking men than are women paired with George Clooney types.

11 Jan 2011

Potential single vaccine for permanent immunity to all influenza

The search for a universal flu vaccine has received a boost from a surprising source: the 2009 H1N1 pandemic flu strain.

10 Jan 2011

Vaccines for alcoholism and cocaine addiction coming soon

In a latest development, researchers from Chile have come up with a vaccine to cure alcoholics. It will help them kick the habit by creating a sensation of a terrible hangover after just a few drinks. The mechanism by which this vaccine acts is by neutralizing a group of enzymes that help the body to break down alcohol. When the enzymes aldehyde dehydrogenase is disabled the body accumulates the alcohol to create the hangovers after just a few drinks.

9 Jan 2011

immunity News and Research

Rotavirus vaccine significantly cuts child hospitalizations, study says

Researchers map complex choreography used by immune system's T cells to recognize pathogens

New research says EPO hormone can modulate immune response

Routine rotavirus vaccine shows a significant drop in diarrhea cases: Study

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Study finds link between public transport and risk of catching ARI

Collaborative study may lead to improved influenza vaccine and vaccines for other respiratory virus infections

Convalescent plasma therapy may reduce mortality rate in patients with H1N1 infection: Study

New patented technique offers unprecedented view of DNA damage

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Australians urged to vaccinate babies and care givers against whooping cough

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Michael Cuccione Foundation donates $5 million to support childhood cancer research

Antibodies produced by people who recovered from H1N1 offer clues for universal flu vaccine

Herpes zoster vaccine reduces risk of developing shingles by 55%

Fertile women gravitate toward males with masculine facial features

Potential single vaccine for permanent immunity to all influenza

Vaccines for alcoholism and cocaine addiction coming soon

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News